CURX
NASDAQ · Pharmaceuticals
Curanex Pharmaceuticals Inc
$6.21
+0.43 (+7.44%)
Open$6.31
Previous Close$5.78
Day High$6.31
Day Low$6.13
52W High$13.44
52W Low$3.58
Volume—
Avg Volume14.7K
Market Cap9.06M
P/E Ratio—
EPS$-6.75
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.70M | 1.62M | 1.35M |
| Net Income | 499.2K | 484.2K | 288.0K |
| Profit Margin | 29.3% | 29.9% | 21.3% |
| EBITDA | 775.5K | 724.0K | 543.0K |
| Free Cash Flow | 289.5K | 292.3K | 286.4K |
| Rev Growth | +22.0% | +2.7% | +4.4% |
| Debt/Equity | 0.23 | 0.19 | 0.17 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |